Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3592474rdf:typepubmed:Citationlld:pubmed
pubmed-article:3592474lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:3592474lifeskim:mentionsumls-concept:C0038317lld:lifeskim
pubmed-article:3592474lifeskim:mentionsumls-concept:C0007933lld:lifeskim
pubmed-article:3592474lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:3592474lifeskim:mentionsumls-concept:C1512954lld:lifeskim
pubmed-article:3592474pubmed:issue4lld:pubmed
pubmed-article:3592474pubmed:dateCreated1987-7-22lld:pubmed
pubmed-article:3592474pubmed:abstractTextIntralesional injection of triamcinolone acetonide 5 mg/mL suspension was used in the treatment of 110 cases of chalazion; 92.3% of the cases resolved completely with one to three injections, irrespective of the duration and consistency of the chalazion. Recurrence and yellow deposits were seen at the site of injection in a minority of patients.lld:pubmed
pubmed-article:3592474pubmed:languageenglld:pubmed
pubmed-article:3592474pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3592474pubmed:citationSubsetIMlld:pubmed
pubmed-article:3592474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3592474pubmed:statusMEDLINElld:pubmed
pubmed-article:3592474pubmed:monthAprlld:pubmed
pubmed-article:3592474pubmed:issn0003-4886lld:pubmed
pubmed-article:3592474pubmed:authorpubmed-author:MohanKKlld:pubmed
pubmed-article:3592474pubmed:authorpubmed-author:DhirS PSPlld:pubmed
pubmed-article:3592474pubmed:authorpubmed-author:JainI SISlld:pubmed
pubmed-article:3592474pubmed:authorpubmed-author:MunjalV PVPlld:pubmed
pubmed-article:3592474pubmed:issnTypePrintlld:pubmed
pubmed-article:3592474pubmed:volume18lld:pubmed
pubmed-article:3592474pubmed:ownerNLMlld:pubmed
pubmed-article:3592474pubmed:authorsCompleteYlld:pubmed
pubmed-article:3592474pubmed:pagination158-60lld:pubmed
pubmed-article:3592474pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3592474pubmed:meshHeadingpubmed-meshheading:3592474-...lld:pubmed
pubmed-article:3592474pubmed:meshHeadingpubmed-meshheading:3592474-...lld:pubmed
pubmed-article:3592474pubmed:meshHeadingpubmed-meshheading:3592474-...lld:pubmed
pubmed-article:3592474pubmed:meshHeadingpubmed-meshheading:3592474-...lld:pubmed
pubmed-article:3592474pubmed:meshHeadingpubmed-meshheading:3592474-...lld:pubmed
pubmed-article:3592474pubmed:meshHeadingpubmed-meshheading:3592474-...lld:pubmed
pubmed-article:3592474pubmed:year1986lld:pubmed
pubmed-article:3592474pubmed:articleTitleThe use of intralesional steroids in the treatment of chalazion.lld:pubmed
pubmed-article:3592474pubmed:publicationTypeJournal Articlelld:pubmed